Helus Pharma Inc.
HELP · XNASCIK 1833141fmd_0PVCTTGBHMJSB3WE1N9T600CHBManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Apr 01, 2020 to Mar 31, 2025, 5 periods
| Line item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Total revenues | 1 | 0 | – | – | – |
| Cost of revenue | 1 | 0 | – | – | – |
| Gross profit | 0 | 0 | – | – | – |
| Research and development | 3 | 18 | 25 | 32 | 55 |
| Income tax expense | 0 | 0 | 0 | 0 | 0 |
| Net income | (32) | (68) | (47) | (78) | (113) |